Sailong Pharmaceutical Group Co.,Ltd. (002898.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 1.58B |
| Enterprise value | 1.64B |
| Trailing P/E | 198.01 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.24 |
| Price/book (mrq) | 2.93 |
| Enterprise value/revenue | 5.47 |
| Enterprise value/EBITDA | 59.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.10 |
| 52-week change 3 | -12.85% |
| S&P500 52-week change 3 | 26.24% |
| 52-week high 3 | 20.02 |
| 52-week low 3 | 7.70 |
| 50-day moving average 3 | 9.79 |
| 200-day moving average 3 | 11.99 |
Share statistics
| Avg vol (3-month) 3 | 4.23M |
| Avg vol (10-day) 3 | 1.83M |
| Shares outstanding 5 | 176M |
| Implied shares outstanding 6 | 176.4M |
| Float 8 | 60.15M |
| % held by insiders 1 | 66.09% |
| % held by institutions 1 | 0.57% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.02 |
| Forward annual dividend yield 4 | 0.22% |
| Trailing annual dividend rate 3 | 0.02 |
| Trailing annual dividend yield 3 | 0.22% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 28 Jun 2024 |
| Last split factor 2 | 1.1:1 |
| Last split date 3 | 16 Jul 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 2.65% |
| Operating margin (ttm) | 3.64% |
Management effectiveness
| Return on assets (ttm) | 0.96% |
| Return on equity (ttm) | 1.49% |
Income statement
| Revenue (ttm) | 300.68M |
| Revenue per share (ttm) | 1.71 |
| Quarterly revenue growth (yoy) | -12.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 44.89M |
| Net income avi to common (ttm) | 7.96M |
| Diluted EPS (ttm) | 0.05 |
| Quarterly earnings growth (yoy) | -49.20% |
Balance sheet
| Total cash (mrq) | 58.69M |
| Total cash per share (mrq) | 0.33 |
| Total debt (mrq) | 127.25M |
| Total debt/equity (mrq) | 23.67% |
| Current ratio (mrq) | 1.15 |
| Book value per share (mrq) | 3.05 |
Cash flow statement
| Operating cash flow (ttm) | 23.82M |
| Levered free cash flow (ttm) | -34.74M |
© 2024 Yahoo. All rights reserved.